NCT01769404View on ClinicalTrials.gov

A Study of LY2605541 and Glargine in Participants With Type 1 Diabetes

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Diabetes Mellitus, Type 1
Interventions
BIOLOGICAL

LY2605541

BIOLOGICAL

Insulin Glargine

Trial Locations (1)

41460

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Neuss

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT01769404 - A Study of LY2605541 and Glargine in Participants With Type 1 Diabetes | Biotech Hunter | Biotech Hunter